Cellaa On Is A Belgian Biotechnology Company Based In Mont Saint Guibertwalloniafounded In March 2021The Company Specializes In Regenerative Medicinefocusing On Advanced Cell Therapies For Severe Liver Diseasesparticularly Acute On Chronic Liver Failureaclf Cellaa On Employs Between 10 And 50 People And Has Raised Over $145 Million In Fundingincluding A A 23 Million Round In 2022 The Company S Flagship Producthepastema Is A Clinical Stage Cell Therapy Derived From Liver Stem Cellsit Aims To Treat Aclfa Serious Condition That Can Lead To Multi Organ Failurehepastemautilizes Anti Inflammatory And Regenerative Properties To Help Halt Disease Progression And Support Liver Recoverycellaa On Is Dedicated To Addressing Unmet Medical Needs In Liver Disease Treatmentparticularly For Patients Who Are Ineligible For Liver Transplantsthe Company Collaborates With Clinical And Academic Partners To Advance Its Innovative Therapies
